Impact of RBC Transfusion Less Than 14 Days on Morbidity & Mortality in

Status Terminated

Clinical Trial Summary

The purpose of the transfusion of packed red blood cell is to overcome acute or chronic anemia cause tissue hypoxia. It increases hemoglobin concentration and consequently increase oxygen delivery to peripheral tissues. The perioperative period of major surgery is a field particularly favorable to the development of tissue hypoxia, which is associated with increased mortality and postoperative morbidity. Optimization of oxygen transport to tissues at the preoperative period is accompanied by a significant reduction of these major complications.

Clinical complications (infectious or otherwise) related to transfusion of caps Red Blood cells Caps (RBC)are well known. Many studies seem to evidence the potentially deleterious effect of transfusion, especially in patients with poor condition, related to storage time. Indeed, during storage, impaired blood-related storage is created. It is metabolic, biochemical and molecular levels. Many studies, carried out in particular in cardiac surgery where patients are suitable for transfusion RBC, have focused on the effect of transfusions on consumption and the transport of oxygen to demonstrate the impact of conservation lesions on their role in vivo. In particular, a single-center retrospective American study showed reduction of postoperative complications in patients who received RBC under 14 days.

However one of the confounding factors present is that all transfused RBCs are not leukoreduced (unlike the French transfusion policy). In addition, the greater part of the clinical studies are controversial. That is why we aim to assess, through a retrospective study of data, the impact of transfusion of red red blood cells within 14 days of post-operative morbidity and mortality, compared to the usual transfusion practice in cardiac surgery patients.

Clinical Trial Description

n/a

Study Design

Observational Model: Case Control, Time Perspective: Retrospective

Related Conditions & MeSH terms

Postoperative; Dysfunction Following Cardiac Surgery
Transfusion Related Complication

Clinical Trial Details

NCT number	NCT01915654
Study type	Observational
Source	Centre Hospitalier Universitaire de Besancon
Contact
Status	Terminated
Phase	N/A
Start date	January 2013
Completion date	December 2013

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05699005` - Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO	Phase 1
Recruiting	`NCT06403163` - Transfusion Surveillance in Anaesthesia
Not yet recruiting	`NCT02587845` - Use of Transexamic Acid in Hip Replacement	Phase 3
Completed	`NCT03365999` - Oral Tranexamic Acid vs. Oral Aminocaproic Acid to Reduce Blood Loss and Transfusion After Total Knee Replacement.	Phase 2
Completed	`NCT03784794` - Patient Blood Management for Massive Obstetric Hemorrhage	N/A
Not yet recruiting	`NCT02139995` - West-China Transfusion Score for Critically-ill Patients	Phase 3
Completed	`NCT04513249` - Effects of Therapeutic Plasmaexhange on Viscoelastic Tests in Non-coagulopathic Patients
Not yet recruiting	`NCT03934112` - Impact of Transfusional Practice on the Morbidity and Mortality of Patients in Intensive Care Unit
Completed	`NCT03394274` - Restrictive Versus Liberal Transfusion, Major Surgeries	N/A
Not yet recruiting	`NCT06399536` - Individualized ANH for Non-cardiac Surgery	N/A
Withdrawn	`NCT04388722` - Monitoring Noninvasively for Infusion and Transfusion Optimization	N/A
Completed	`NCT03476005` - Proficiency Based Training to Investigate WBIT	N/A
Recruiting	`NCT03999229` - S-Nitrosylation (SNO) Therapy During Autologous Blood Transfusion	Phase 1
Not yet recruiting	`NCT04413721` - Effects of Packed Red Blood Cell Storage Duration on Pediatric Living Donor Liver Transplantation	N/A
Recruiting	`NCT02461264` - Transfusion Strategy in Hematological Intensive Care Unit	Phase 3
Not yet recruiting	`NCT05696210` - Evaluation of the 1-year Prognosis of Patients Under Veno-arterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock With Blood Transfusion Requirement
Completed	`NCT04286984` - Implementation of a Patient Blood Management Program in Gastric Cancer Surgery
Completed	`NCT03764813` - Cord Blood Transfusion In Preterm Neonates (CB-TrIP)
Withdrawn	`NCT04383756` - Utilization of Donor Whole Blood for Blood Transfusion in Deceased Donor Liver Transplantation	Early Phase 1
Completed	`NCT03815773` - PRospective Multicenter Observational Study on Transfusion Practice in Vv-ECMO Patients: The PROTECMO Study

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Impact of RBC Transfusion Less Than 14 Days on Morbidity and Mortality in Cardiac Surgical Patients — CGRCard

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms